{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:16:23Z","timestamp":1787062583792,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd014624","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000}}],"reference-count":84,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014624.pub2","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T20:15:58Z","timestamp":1750882558000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Brexanolone, zuranolone and related neurosteroid GABA\n                    <sub>A<\/sub>\n                    receptor positive allosteric modulators for postnatal depression"],"prefix":"10.1002","volume":"2025","author":[{"given":"Claire A","family":"Wilson","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology and Neuroscience; King's College London; London UK"},{"name":"South London and Maudsley NHS Foundation Trust; London United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Robertson","sequence":"additional","affiliation":[{"name":"Cochrane Common Mental Disorders; University of York; York UK"},{"name":"Centre for Reviews and Dissemination; University of York; York UK"},{"name":"Evidence Production and Methods; Cochrane Central Executive; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn","family":"Ayre","sequence":"additional","affiliation":[{"name":"Division of Psychiatry; University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L","family":"Hendon","sequence":"additional","affiliation":[{"name":"Cochrane Common Mental Disorders; University of York; York UK"},{"name":"Centre for Reviews and Dissemination; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dawson","sequence":"additional","affiliation":[{"name":"Centre for Academic Mental Health, Bristol Population Health Science Institute; University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Bridges","sequence":"additional","affiliation":[{"name":"Cochrane Central Study Identification Service, Publishing and Technology; Cochrane; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Khalifeh","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology and Neuroscience; King's College London; London UK"},{"name":"South London and Maudsley NHS Foundation Trust; London United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"10.1002\/14651858.CD014624.pub2-BIB0001|cit1","doi-asserted-by":"crossref","unstructured":"Clayton A Cutler AJ Deligiannidis KM Lasser R Sankoh AJ Doherty J Clinical efficacy of a 2-week treatment course of Zuranolone for the treatment of major depressive disorder and postpartum depression: outcomes from the clinical development program European Psychiatry Conference: 30th European Congress of Psychiatry, EPA 2022. Virtual. 65(Suppl 1):S97-S98 2022","DOI":"10.1192\/j.eurpsy.2022.282"},{"issue":"1","key":"10.1002\/14651858.CD014624.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1097\/01.AOG.0000825932.04024.e0","article-title":"Overview of the rapid antidepressant effects observed in the Zuranolone Clinical Development Program","volume":"139","author":"Clayton","year":"2022","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0003|cit3","unstructured":"Deligiannidis KM Meltzer-Brody S Gunduz-Bruce H Doherty J Jonas J Li S Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial JAMA Psychiatry e211559 10.1001\/jamapsychiatry.2021.1559"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Error in Figure 3 JAMA Psychiatry 2022 79 7 740","DOI":"10.1001\/jamapsychiatry.2022.1274"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0005|cit5","doi-asserted-by":"crossref","unstructured":"Error in Results JAMA Psychiatry 2023 80 2 191","DOI":"10.1001\/jamapsychiatry.2022.4181"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0006|cit6","unstructured":"A study to evaluate SAGE-217 in subjects with severe postpartum depression clinicaltrials.gov\/ct2\/show\/NCT02978326"},{"issue":"1","key":"10.1002\/14651858.CD014624.pub2-BIB0007|cit7","first-page":"S93","article-title":"Rapid improvements in MADRS with zuranolone in major depressive disorder and postpartum depression: results from the LANDSCAPE\/NEST clinical development programmes","volume":"66","author":"Clayton","year":"2023","journal-title":"European Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD014624.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1176\/appi.ajp.20220785","article-title":"Zuranolone for the treatment of postpartum depression","volume":"180","author":"Deligiannidis","year":"2023","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0009|cit9","unstructured":"A randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of SAGE-217 in the treatment of adults with severe postpartum depression clinicaltrialsregister.eu"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0010|cit10","unstructured":"A study to evaluate the efficacy and safety of SAGE-217 in participants with severe postpartum depression (PPD) clinicaltrials.gov\/study\/NCT04442503"},{"issue":"10093","key":"10.1002\/14651858.CD014624.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0140-6736(17)31264-3","article-title":"Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial","volume":"390","author":"Kanes","year":"2017","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0012|cit12","unstructured":"A study to evaluate SAGE-547 in patients with severe postpartum depression ClinicalTrials.gov\/show\/NCT02614547"},{"issue":"10153","key":"10.1002\/14651858.CD014624.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(18)32288-8","article-title":"Published Erratum","volume":"392","author":"Department of Error","year":"2018","journal-title":"Lancet"},{"issue":"10152","key":"10.1002\/14651858.CD014624.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0015|cit15","unstructured":"A study to evaluate efficacy and safety of SAGE-547 in participants with severe postpartum depression (547-PPD-202B) clinicaltrials.gov\/ct2\/show\/NCT02942004"},{"issue":"10153","key":"10.1002\/14651858.CD014624.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(18)32288-8","article-title":"Published Erratum","volume":"392","author":"Department of Error","year":"2018","journal-title":"Lancet"},{"issue":"10152","key":"10.1002\/14651858.CD014624.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0018|cit18","unstructured":"A study to evaluate safety and efficacy of SAGE-547 in participants with moderate postpartum depression (547-PPD-202C) clinicaltrials.gov\/ct2\/show\/NCT02942017"},{"issue":"10 Suppl","key":"10.1002\/14651858.CD014624.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1016\/j.biopsych.2019.03.459","article-title":"Safety and efficacy of intravenous ganaxolone in severe postpartum depression: results from a double-blind, placebo-controlled phase 2 study","volume":"85","author":"Gutierrez-Esteinou","year":"2019","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0020|cit20","unstructured":"A clinical trial of intravenous ganaxolone in women with postpartum depression clinicaltrials.gov\/ct2\/show\/NCT03228394"},{"issue":"9","key":"10.1002\/14651858.CD014624.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.biopsych.2020.02.242","article-title":"A phase 3, multicenter, double-blind, randomized, placebo-controlled study evaluating the efficacy of SAGE-217 in the treatment of adult patients with major depressive disorder","volume":"87","author":"Clayton","year":"2020","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0022|cit22","unstructured":"A study to evaluate the efficacy of SAGE-217 in the treatment of adult subjects with major depressive disorder clinicaltrials.gov\/ct2\/show\/NCT03672175"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.euroneuro.2018.11.1034","article-title":"Health-related quality of life in a phase 2, randomized, placebo-controlled trial of the GABA(A)R modulator SAGE-217 in major depressive disorder","volume":"29","author":"Bonthapally","year":"2019","journal-title":"European Neuropsychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD014624.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1056\/NEJMoa1815981","article-title":"Trial of SAGE-217 in patients with major depressive disorder","volume":"381","author":"Gunduz-Bruce","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD014624.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.biopsych.2018.02.333","article-title":"SAGE-217 a first in class GABAA receptor positive allosteric modulator in major depressive disorder: a multicenter, randomized, double-blind, phase 2 placebo-controlled trial","volume":"83","author":"Gunduz-Bruce","year":"2018","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.euroneuro.2018.11.1036","article-title":"SAGE-217 in major depressive disorder: a multicenter, randomized, double-blind, phase 2 placebo-controlled trial","volume":"29","author":"Gunduz-Bruce","year":"2019","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0027|cit27","unstructured":"A study to evaluate sage-217 in participants with moderate to severe major depressive disorder clinicaltrials.gov\/ct2\/show\/NCT03000530"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014624.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"S554","DOI":"10.1016\/j.ajog.2018.11.873","article-title":"850: Evaluation of breast milk concentrations following brexanolone iv administration to healthy lactating women","volume":"220","author":"Hoffmann","year":"2019","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0029|cit29","doi-asserted-by":"crossref","unstructured":"Hoffmann E Wald J Dray D Colquhoun H Brexanolone injection administration to lactating women: breast milk allopregnanolone levels Obstetrics and Gynecology. Conference: 67th Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists Nashville, TN 2019 Suppl 1","DOI":"10.1097\/01.AOG.0000558846.15461.70"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0030|cit30","unstructured":"A clinical trial of oral ganaxolone in women with postpartum depression clinicaltrials.gov\/ct2\/show\/NCT03460756"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0031|cit31","unstructured":"A study to evaluate SAGE-217 in adult participants with major depressive disorder (MDD) clinicaltrials.gov\/ct2\/show\/NCT03864614"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0032|cit32","unstructured":"Expanded access protocol of Zulresso\u2122 (brexanolone) injection for adult patients with postpartum depression clinicaltrials.gov\/ct2\/show\/NCT03924492"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0033|cit33","unstructured":"A study to evaluate multimodal neuroimaging parameters in women with postpartum depression who are receiving Zulresso\u2122 (brexanolone) clinicaltrials.gov\/ct2\/show\/NCT04273191"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0034|cit34","unstructured":"A study to evaluate the efficacy of SAGE-217 in the treatment of adult participants with major depressive disorder (MDD) clinicaltrials.gov\/ct2\/show\/NCT04442490"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0035|cit35","unstructured":"A study to assess the safety of brexanolone in the treatment of adolescent female participants with postpartum depression (PPD) clinicaltrials.gov\/ct2\/show\/NCT03665038"},{"issue":"1 Supplement","key":"10.1002\/14651858.CD014624.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/j.ajog.2021.11.149","article-title":"Brexanolone in adolescent patients with postpartum depression: results from the phase 3, open-label CHICKADEE study","volume":"226","author":"Riesenberg","year":"2022","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD014624.pub2-BIB0037|cit37","first-page":"481","article-title":"Postpartum depression. Zuranolone improves HAM-D-17 score during and after 2-week therapy","volume":"42","author":"Reisdorf","year":"2021","journal-title":"Krankenhauspharmazie"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0038|cit38","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM\u20135)","author":"American Psychiatric Association","year":"2013"},{"issue":"7247","key":"10.1002\/14651858.CD014624.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/bmj.320.7247.1468","article-title":"Statistics notes: the odds ratio","volume":"320","author":"Bland","year":"2000","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD014624.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013560.pub2","article-title":"Antidepressant treatment for postnatal depression","author":"Brown","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD014624.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1192\/bjp.166.2.191","article-title":"Course and recurrence of postnatal depression. Evidence for the specificity of the diagnostic concept","volume":"166","author":"Cooper","year":"1995","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40263-019-00672-w","article-title":"Using matching-adjusted indirect comparisons and network meta-analyses to compare efficacy of brexanolone injection with selective serotonin reuptake inhibitors for treating postpartum depression","volume":"33","author":"Cooper","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0043|cit43","unstructured":"Covidence Veritas Health Innovation 2019"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1192\/bjp.150.6.782","article-title":"Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale","volume":"150","author":"Cox","year":"1987","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0045|cit45","unstructured":"Deeks JJ Higgins JP Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41386-018-0242-2","article-title":"Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic resonance imaging and spectroscopy study","volume":"44","author":"Deligiannidis","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0313-7","article-title":"Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study","volume":"186","author":"Epperson","year":"2006","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD014624.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/03007995.2021.1902295","article-title":"Achieving clinical response in postpartum depression leads to improvement in health-related quality of life","volume":"37","author":"Gerbasi","year":"2021","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0884217504266915","article-title":"Postpartum depression beyond the early postpartum period","volume":"33","author":"Goodman","year":"2004","journal-title":"Journal of Obstetrics, Gynecology and Neonatal Nursing"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0050|cit50","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2020"},{"issue":"34","key":"10.1002\/14651858.CD014624.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"E1085","DOI":"10.1503\/cmaj.170088","article-title":"Perinatal suicide in Ontario, Canada: a 15-year population-based study","volume":"189","author":"Grigoriadis","year":"2017","journal-title":"Canadian Medical Association Journal"},{"issue":"4","key":"10.1002\/14651858.CD014624.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"British Journal of Social and Clinical Psychology"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0053|cit53","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0054|cit54","unstructured":"Higgins JP Li T Chapter 6: Choosing effect measures and computing estimates of effect [last updated August 2023]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from www.training.cochrane.org\/handbook"},{"issue":"9956","key":"10.1002\/14651858.CD014624.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0140-6736(14)61276-9","article-title":"Non-psychotic mental disorders in the perinatal period","volume":"384","author":"Howard","year":"2014","journal-title":"Lancet"},{"issue":"9956","key":"10.1002\/14651858.CD014624.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(14)61278-2","article-title":"Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period","volume":"384","author":"Jones","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD014624.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(16)00003-1","article-title":"Suicide in perinatal and non-perinatal women in contact with psychiatric services: 15 year findings from a UK national inquiry","volume":"3","author":"Khalifeh","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0058|cit58","volume-title":"Saving Lives, Improving Mothers\u2019 Care - Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2015-17","author":"Knight","year":"2019"},{"issue":"7","key":"10.1002\/14651858.CD014624.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1210\/jcem.85.7.6675","article-title":"Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients","volume":"85","author":"Luisi","year":"2000","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fncel.2019.00083","article-title":"Neuroactive steroids and GABAergic involvement in the neuroendocrine dysfunction associated with major depressive disorder and postpartum depression","volume":"13","author":"Maguire","year":"2019","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"5","key":"10.1002\/14651858.CD014624.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0269881117699361","article-title":"British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017","volume":"31","author":"McAllister-Williams","year":"2017","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"100212","DOI":"10.1016\/j.ynstr.2020.100212","article-title":"Allopregnanolone in postpartum depression: role in pathophysiology and treatment","volume":"12","author":"Meltzer-Brody","year":"2020","journal-title":"Neurobiology of Stress"},{"issue":"21","key":"10.1002\/14651858.CD014624.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1001\/jama.296.21.2582","article-title":"New parents and mental disorders: a population-based register study","volume":"296","author":"Munk-Olsen","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD014624.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archgenpsychiatry.2008.528","article-title":"Risks and predictors of readmission for a mental disorder during the postpartum period","volume":"66","author":"Munk-Olsen","year":"2009","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD014624.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"e919","DOI":"10.1038\/tp.2016.190","article-title":"Perinatal psychiatric episodes: a population-based study on treatment incidence and prevalence","volume":"6","author":"Munk-Olsen","year":"2016","journal-title":"Translational Psychiatry"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0066|cit66","unstructured":"National Institute for Health and Care Excellence Antenatal and postnatal mental health: clinical management and service guidance. Clinical guideline [CG192]; published December 2014; last updated February 2020 Available at www.nice.org.uk\/guidance\/cg192\/resources\/antenatal-and-postnatal-mental-health-clinical-management-and-service-guidance-pdf-35109869806789"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-clinpsy-050212-185612","article-title":"Postpartum depression: current status and future directions","volume":"9","author":"O'Hara","year":"2013","journal-title":"Annual Review of Clinical Psychology"},{"issue":"8","key":"10.1002\/14651858.CD014624.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1089\/jwh.2007.0631","article-title":"Preferences and perceived barriers to treatment for depression during the perinatal period","volume":"17","author":"O'Mahen","year":"2008","journal-title":"Journal of Women's Health"},{"issue":"4","key":"10.1002\/14651858.CD014624.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.psyneuen.2005.11.006","article-title":"Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity","volume":"31","author":"Paoletti","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0070|cit70","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"6","key":"10.1002\/14651858.CD014624.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"342","DOI":"10.9740\/mhc.2022.12.342","article-title":"Patient-reported perceptions of brexanolone in the treatment of postpartum depression: a qualitative analysis","volume":"12","author":"Salwan","year":"2023","journal-title":"Mental Health Clinician"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0072|cit72","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch14"},{"issue":"2","key":"10.1002\/14651858.CD014624.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00737-018-0891-5","article-title":"Is depression more likely following childbirth? A population-based study","volume":"22","author":"Silverman","year":"2019","journal-title":"Archives of Women's Mental Health"},{"issue":"6","key":"10.1002\/14651858.CD014624.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archpsyc.1978.01770300115013","article-title":"Research diagnostic criteria: rationale and reliability","volume":"35","author":"Spitzer","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"9956","key":"10.1002\/14651858.CD014624.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(14)61277-0","article-title":"Effects of perinatal mental disorders on the fetus and child","volume":"384","author":"Stein","year":"2014","journal-title":"Lancet"},{"issue":"22","key":"10.1002\/14651858.CD014624.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1056\/NEJMcp1607649","article-title":"Postpartum depression","volume":"375","author":"Stewart","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev-med-041217-011106","article-title":"Postpartum depression: pathophysiology, treatment, and emerging therapeutics","volume":"70","author":"Stewart","year":"2019","journal-title":"Annual Review of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD014624.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection","volume":"30","author":"Sherbourne","year":"1992","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0079|cit79","unstructured":"World Health Organization International classification of diseases for mortality and morbidity statistics (11th Revision). 18 June 2018 www.who.int\/classifications\/icd\/en\/"},{"issue":"7","key":"10.1002\/14651858.CD014624.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1176\/appi.ajp.161.7.1290","article-title":"Prevention of postpartum depression: a pilot randomized clinical trial","volume":"161","author":"Wisner","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD014624.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamapsychiatry.2013.87","article-title":"Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings","volume":"70","author":"Wisner","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/14651858.CD014624.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jad.2017.05.003","article-title":"A systematic review and meta-regression of the prevalence and incidence of perinatal depression","volume":"219","author":"Woody","year":"2017","journal-title":"Journal of Affective Disorders"},{"issue":"7","key":"10.1002\/14651858.CD014624.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Losing participants before the trial ends erodes credibility of findings","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"issue":"5","key":"10.1002\/14651858.CD014624.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014624","article-title":"Brexanolone and related neurosteroid GABA(A) positive allosteric modulators for postnatal depression","author":"Wilson","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:03:54Z","timestamp":1774541034000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014624.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":84,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014624.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}